Quiana C Wilkerson-Vidal

Dr. Quiana C Wilkerson-Vidal

Chemistry, University of Alabama in Huntsville, Huntsville, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2007 in Brain, Behavior and Evolution
Verified
Journal Article
Closed access
AOAlexander G. Ophir
Alexander G. Ophir
OCOndi L. Crino
Ondi L. Crino
Quiana C Wilkerson-VidalQuiana C Wilkerson-Vidal
Quiana C Wilkerson-Vidal
JWJerry O. Wolff
Jerry O. Wolff
SPSteven M. Phelps
Steven M. Phelps
In the socially monogamous prairie vole, Microtus ochrogaster, male affiliation and parental care are influenced by the neuropeptide arginine vasopressin and expression of its receptor V1aR. If parental care and adult affiliation can be considered a behavioral syndrome, females might use male affiliative behavior as a cue to choose a good father. We investigated three questions: (1) do females prefer affiliative males; (2) do males that are affiliative with females demonstrate paternal behavior with pups; and (3) is male V1aR expression related to male behavior or female preference? We evaluated paternal behavior of individual males, then offered sexually receptive females a choice between paternal and non-paternal males and measured the proportion of time each male spent engaging in affiliative behavior with the choosing female. Females showed a preference for more affiliative males, but affiliation was not predictive of paternal care. Thus females did not discriminate between paternal and non-paternal males. Perhaps surprisingly, paternal behavior was correlated with the relative amount of aggression males directed toward females. Finally, females did not discriminate between males with high or low V1aR expression and V1aR expression did not predict male affiliative behavior or parental care. These data suggest that male affiliative behavior, but not paternal care, is associated with female mate choice.

1 November 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
MWMadushika M. Wimalarathne
Madushika M. Wimalarathne
Quiana C Wilkerson-VidalQuiana C Wilkerson-Vidal
Quiana C Wilkerson-Vidal
EHEmily C. Hunt
Emily C. Hunt
SLSharifa Tahirah Love-Rutledge
Sharifa Tahirah Love-Rutledge
Human leukocyte antigen F locus adjacent transcript 10 (FAT10) is a ubiquitin-like protein that targets proteins for degradation. TNFα and IFNγ upregulate FAT10, which increases susceptibility to inflammation-driven diseases like nonalcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatocellular carcinoma (HCC). It is well established that inflammation contributes to fatty liver disease, but how inflammation contributes to upregulation and what genes are involved is still poorly understood. New evidence shows that FAT10 plays a role in mitophagy, autophagy, insulin signaling, insulin resistance, and inflammation which may be directly associated with fatty liver disease development. This review will summarize the current literature regarding FAT10 role in developing liver diseases and potential therapeutic targets for nonalcoholic/alcoholic fatty liver disease and hepatocellular carcinoma.

20 December 2022 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
Quiana C Wilkerson-VidalQuiana C Wilkerson-Vidal
Quiana C Wilkerson-Vidal
MWMadushika Wimalarathne
Madushika Wimalarathne
GCGenoah Collins
Genoah Collins
JWJames Gerard Wolfsberger
James Gerard Wolfsberger
ACAmelia Clopp
Amelia Clopp
SLSharifa Tahirah Love-Rutledge
Sharifa Tahirah Love-Rutledge

19 April 2024 in Endocrines
Verified
Journal Article
Open access
PDF file
Quiana C Wilkerson-VidalQuiana C Wilkerson-Vidal
Quiana C Wilkerson-Vidal
MWMadushika M. Wimalarathne
Madushika M. Wimalarathne
EHEmily C Hunt
Emily C Hunt
LMLuis Mercado
Luis Mercado
Moses Adaji DavidMoses Adaji David
Moses Adaji David
BVBernhard W Vogler
Bernhard W Vogler
Most patients with non-alcoholic steatohepatitis (NASH) have insulin resistance, and there is a near-universal association between NASH and insulin resistance. Insulin resistance induces lipid accumulation in the liver, leading to the development of metabolic syndrome. However, most NASH rodent models fail to develop metabolic syndrome. LEW.1WR1 rats that are 23 weeks old showed increased body mass, epididymal fat, and liver mass, suggesting obesity-driven metabolic dysfunction. We have characterized steatosis, inflammation, Mallory–Denk body formation with hematoxylin and eosin (H&E), and fibrosis with Trichome blue staining. The presence of hepatic fibrosis with other features of NASH described above is one of the major strengths of this model since most of the currently available NASH models do not develop microvesicular steatosis or fibrosis. Together with the other important features of NASH described above, we confirm that male LEW.1WR1 rats develop NASH and insulin resistance with a standard diet.

Verified
Journal Article
Open access
PDF file
Quiana C Wilkerson-VidalQuiana C Wilkerson-Vidal
Quiana C Wilkerson-Vidal
Moses Adaji DavidMoses Adaji David
Moses Adaji David
JWJames Gerard Wolfsberger
James Gerard Wolfsberger
MWMadushika M. Wimalarathne
Madushika M. Wimalarathne
EFEvann Fowler
Evann Fowler
SLSharifa Tahirah Love-Rutledge
Sharifa Tahirah Love-Rutledge
Characterizing changes in beta cell function during prolonged hyperinsulinemia and dietary stress is important to study to prevent diseases like metabolic dysfunction-associated steatotic liver disease and insulin resistance. This research investigates how a moderate sucrose (MS) diet affects insulin resistance and β-cell mass in two rat strains: LEW.1WR1 and Wistar Furth (WF). LEW.1WR1 rats seem to be sensitive to beta cell disruptions as weanlings. Twenty-one male LEW.1WR1 rats and sixteen male WF rats were studied over 18 weeks. The rats were divided into groups and given either the control or MS diet. Their body weight was monitored twice a week. Insulin tolerance tests (ITTs) and fasting blood glucose measurements were taken at intervals. Urine samples were analyzed to assess metabolic shifts, and pancreas tissue was examined to evaluate changes in β-cell mass. The LEW.1WR1 rats became overweight and showed higher insulin resistance than the WF rats. Both strains of rats on the MS diet displayed changes in urine metabolite profiles in terms of levels of lactic acid and alanine. This study highlights the impact or lack thereof of a moderate sucrose diet on body mass, insulin resistance, and β-cell mass, with notable effects observed specifically in LEW.1WR1 rats. These findings contribute to our understanding of how dietary sugar intake can affect metabolism when observed in models sensitive to metabolic defects.